Hsp90 as a modulator of pathogenicity, virulence and transmission in veterinary infections caused by Theileria and Babesia species
Hsp90 as a modulator of pathogenicity, virulence and transmission in veterinary infections caused by Theileria and Babesia species
批准号:
BB/L004542/1
负责人:
Eileen Devaney
金额:
$46.38万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --
中文摘要
就大规模的人类贫困而言,南亚农村地区是地球上受灾最严重的地区之一。仅在印度,就有4亿人可能被认为生活在极端贫困中。其中许多人依靠奶牛获得食物和收入。增加牲畜产量是促进减贫的一个重要途径。然而,牲畜生产力受到诸如环芽孢杆菌等病原体的阻碍。仅在印度,每年因环虫感染造成的损失估计在4亿美元左右。由于对巴贝斯虫感染的研究较少,因此很难对印度巴贝斯虫感染造成的潜在损失进行统计,但感染正在上升,可能是由于气候变化和蜱虫媒介传播的增加。最近的一项血清患病率研究表明,来自北方邦和旁遮普邦流行区的牛的感染率为56%。这两种寄生虫都是由蜱虫传播的,当蜱虫吸食血液时感染牛。感染可导致死亡,这对拥有少量牲畜的贫困农民来说是毁灭性的。那些在感染中幸存下来的动物的生产力显著下降。因此,迫切需要新的控制措施来打破感染循环。对于热带血吸虫病和巴贝斯虫病,目前的控制依赖于使用活疫苗、药物治疗或使用杀螨剂,所有这些方法都有各种局限性。质量控制和冷链维护方面的困难,限制了向印度农村地区大量动物提供活疫苗。毒力的恢复是可能的,并且已经发生了通过巴贝斯虫疫苗传播病毒病原体的情况。现有的活疫苗不能诱导无菌免疫,接种过疫苗的动物很可能被感染,从而大大降低了它们的生产力。虽然杂交牛对感染的抵抗力更强,但这是有回报的,因为相对于欧洲牛的产量减少了,而且杂交小牛仍然容易感染疾病。布巴伐酮等药物可以杀死希勒菌,但价格昂贵;此外,世界各地都报告了耐药性,这是一个日益严重的威胁。治疗巴贝斯虫感染的药物也同样有限:米米唑是英国唯一获得许可的药物,需要很长的停药期。在世界上的一些地区,人们广泛使用杀螨剂来控制蜱虫,但这些化学品产生的抗药性和对环境的破坏限制了它们的长期用途。对其他顶复合体寄生虫的研究已经证明了Hsp90在分化、感染和毒力方面的重要作用。在许多其他系统中,Hsp90是一个特性良好的分子,重要的是,许多特定的小分子抑制剂是可用的。T. annulata感染的细胞具有肿瘤细胞的几个特征(不受控制的增殖,转移能力),并且由于Hsp90在许多癌细胞中维持转化表型方面起着重要作用,我们认为它可能是了解T. annulata感染致病性的关键。此外,设计用于肿瘤的Hsp90小分子抑制剂的可用性,为将这些化合物重新用于牲畜的重要感染提供了潜力。
英文摘要
In terms of wide-scale human poverty, rural regions of South Asia are some of the most afflicted places on earth. In India alone, 400 million people may be considered to live in extreme poverty. Many of these people are dependent on dairy cattle for food and income. Increased production from livestock represents an important way to contribute to poverty reduction. However livestock productivity is impeded by the presence of pathogens such as Theileria annulata. In India alone, losses due to T. annulata infection are estimated to be in the region of $400 million per annum. It is more difficult to put a figure on potential losses due to Babesia infection in India as this parasite is less well studied, but infections are on the rise, possibly due to climate change and the increased spread of the tick vector. A recent sero-prevalence study indicated infection levels of 56% in cattle from endemic zones of Uttar Pradesh and Punjab. Both parasites are transmitted by ticks and infect cattle when the tick takes a blood meal. Infection can result in death, which is devastating for poor farmers with a small number of animals. Those animals that survive infection show significant reductions in productivity. Thus new control measures are desperately needed to break the cycle of infection. For both tropical theileriosis and babesiosis, current control relies either on the use of a live vaccine, drug treatment, or the application of acaricides, all of which suffer from various limitations. Difficulties with quality control and the maintenance of a cold-chain, restricts delivery of the live vaccines to large numbers of animals across rural India. Reversion to virulence is possible and transmission of viral pathogens via the Babesia vaccine has occurred. The available live vaccines do not induce a sterile immunity, and vaccinated animals are likely to become infected, significantly reducing their productivity. While crossbred cattle are more resistant to infection, there is a pay-off because production relative to European cattle is reduced, and crossbred calves are still susceptible to disease. Drugs, such as buparvaquone, kill Theileria but are expensive; additionally drug resistance has been reported from different parts of the world and is a growing threat. Drugs for the treatment of Babesia infections are similarly limited: Imizol, the only licensed drug in the UK requires a long withdrawal period. In some parts of the world acarcidides are extensively used to control ticks, but the development of resistance and the environmental damage associated with these chemicals limits their long-term usefulness. Studies in other apicomplexan parasites have demonstrated an essential role for Hsp90 in differentiation, infection and virulence. Hsp90 is a well-characterised molecule in many other systems and importantly many specific small molecule inhibitors are available. T. annulata infected cells adopt several characteristics of tumour cells (uncontrolled proliferation, ability to metastasize) and, as Hsp90 plays an important role in many cancer cells in maintaining the transformed phenotype, we believe that it may hold the key to understanding the pathogenicity of Theileria infection. In addition, the availability of small molecule inhibitors of Hsp90, designed for use in tumours, offers the potential for repurposing of these compounds to important infections of livestock.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1111/cmi.12669
发表时间:
2017-03
期刊:
Cellular microbiology
影响因子:
3.4
作者:
[Kinnaird JH, Singh M, Gillan V, Weir W, Calder ED, Hostettler I, Tatu U, Devaney E, Shiels BR]
通讯作者:
Shiels BR
Characterisation of infection associated microRNA and protein cargo in extracellular vesicles of Theileria annulata infected leukocytes.
感染的特征在于感染的白细胞的细胞外囊泡中相关的microRNA和蛋白质货物的表征。
DOI:
10.1111/cmi.12969
发表时间:
2019-01
期刊:
Cellular microbiology
影响因子:
3.4
作者:
[Gillan V, Simpson DM, Kinnaird J, Maitland K, Shiels B, Devaney E]
通讯作者:
Devaney E
Development of joint research proposal (BBSRC-NSF) on the role of wildlife migration in the parasite dynamics of large herbivores
-
批准号:BB/S013725/1
-
项目类别:Research Grant
-
资助金额:$0.13万
-
财政年份:2018
-
负责人:Eileen Devaney
-
依托单位:
The BUG consortium Building Upon the Genome: using H. contortus genomic resources to develop novel interventions to control endemic GI parasites
-
批准号:BB/M003949/1
-
项目类别:Research Grant
-
资助金额:$375.71万
-
财政年份:2015
-
负责人:Eileen Devaney
-
依托单位:
A comparative analysis of Hsp90 and its possible role in drug resistance in nematode parasites
-
批准号:BB/E013473/1
-
项目类别:Research Grant
-
资助金额:$55.77万
-
财政年份:2007
-
负责人:Eileen Devaney
-
依托单位:
国内基金
海外基金
高精度全硅基单芯片集成数字式六轴微机械电子罗盘传感器研究
-
批准号:61504159
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2015
-
负责人:陈方
-
依托单位: